The device uses AI detection of colonic mucosal lesions during colonoscopy procedures, supporting in detecting and removing pre-cancerous lesions.
The device uses both white light imaging and linked color imaging. Additionally, the system was trained on images captured by Fujifilm endoscopy imaging equipment.
Fujifilm saw 17% higher adenoma per colonoscopy when compared to conventional colonoscopy. The company plans to make the device commercially available this spring after a market evaluation.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
